Suchergebnisse - "Ruth, Jason R"

PubPharm (13)

1

Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease

enthalten in: Blood advances | 2021

von Pierson, S. | Shenoy, S. | Oromendia, A. | +22

2

Cellular dormancy in minimal residual disease following targeted therapy

enthalten in: Breast cancer research : BCR | 2021

von Ruth, J. | Pant, D. | Pan, T. | +9

3

Cellular dormancy in minimal residual disease following targeted therapy

enthalten in: Breast cancer research | 2021

von Ruth, J. | Pant, D. | Pan, T. | +9

4

Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease

enthalten in: The Journal of clinical investigation | 2019

von Fajgenbaum, D. | Langan, R. | Japp, A. | +20

CommentIn: J Clin Invest. 2019 Oct 1;129(10):4086-4088. - PMID 31524635

5

Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease

enthalten in: PloS one | 2019

von Nabel, C. | Sameroff, S. | Shilling, D. | +13

6

The collaborative network approach : a new framework to accelerate Castleman's disease and other rare disease research

enthalten in: The Lancet. Haematology | 2016

von Fajgenbaum, D. | Ruth, J. | Kelleher, D. | +1

CommentOn: Lancet Haematol. 2016 Apr;3(4):e163-75. - PMID 27063975

7

Idiopathic multicentric Castleman's disease : a systematic literature review

enthalten in: The Lancet. Haematology | 2016

von Liu, A. | Nabel, C. | Finkelman, B. | +7

CommentIn: Lancet Haematol. 2016 Apr;3(4):e150-2. - PMID 27063967

8

MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells

enthalten in: Science (New York, N.Y.) | 2016

von Kryukov, G. | Wilson, F. | Ruth, J. | +18

CommentIn: Nat Rev Cancer. 2016 Apr;16(4):197. - PMID 26965077

9

MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells

Erschienen: 2016

von Kryukov, G. | Wilson, F. | Ruth, J. | +18

10

Taking Control of Castleman Disease : Leveraging Precision Medicine Technologies to Accelerate Rare Disease Research

enthalten in: The Yale journal of biology and medicine | 2015

von Newman, S. | Jayanthan, R. | Mitchell, G. | +8